Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version — Stella

Home/Transgenderism/

View on ClinicalTrials.gov

Recruiting

Back to Transgenderism trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

University of California, San Diego, San Diego, California

Key details

Phase

Post-approval study

Sponsor

University of California, San Diego

Collaborators

National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Enrollment target

~80 participants

Started

December 2025

Primary completion

November 2028

Age range

18 Years – 35 Years

Sex

Female only

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.